Waldencast Investors

Waldencast Investors

Waldencast FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

OBAGI FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

MILK FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

Results & presentations

NASDAQ: +0.01 (0.58%)

WALD $1.73
stock information

EVENTS

Next

Participation in Upcoming event

All EVENTS

Press releases

Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel

Waldencast Announces Sale of Obagi Medical to Bridgepoint

All press releases

contact investor relations